Entra ASA (ENTRA)
Oslo Stock Exchange · Norway · prices in NOK · close of 23 Oct 2026
Key indicators
| Last close | NOK 93.00 |
|---|---|
| 52-week range | 89.90 – 118.80 |
| Return, 1 month / 3 months | −7.0% / −11.4% |
| Return, 1 year / 3 years | −19.7% / +11.8% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 17.5% |
| Worst drawdown (1 year) | -22.5% |
| Average daily value traded | 10.28M NOK |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Entra ASA is a Norwegian real estate company that owns, manages and develops office properties. Its buildings are located in Oslo and other Norwegian cities, and its tenants are mainly businesses and public sector organisations that lease office space. The company also carries out redevelopment and new construction projects on its own properties, and it is based in Norway.
The shares are listed on the Oslo Stock Exchange in Norway under the code ENTRA, and the price on this page is in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Entra ASA (ENTRA) trades on the Oslo Stock Exchange in Norway. It last closed at NOK 93.00 on 23 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 173 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 19.7% and over the last three months it fell 11.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 35 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.6% | ||
| From 52-week high | -20.5% | ||
| Momentum | 28 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -11.4% | ||
| 6-month return | -11.8% | ||
| 12-month return, skipping the last month | -13.6% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 17.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.5% | ||
| Liquidity | 72 · Strong | Trades actively. | |
| Average daily value traded | 10.28M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 19 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 4 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.8% |
|---|---|
| 1 month | −7.0% |
| 3 months | −11.4% |
| 6 months | −11.8% |
| 1 year | −19.7% |
| 3 years | +11.8% |
| 5 years | −52.1% |
Signals
| 50-day / 200-day average | 99.16 / 105.16 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.37 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Apr 2026 | NOK 1.1000 |
| 20 Oct 2025 | NOK 1.1000 |
| 26 Apr 2023 | NOK 2.5000 |
| 25 Oct 2022 | NOK 2.6000 |
| 25 Apr 2022 | NOK 2.6000 |
| 4 Oct 2021 | NOK 2.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.